Healthcare and consumer staples: dividend records and recent sales growth
Johnson & Johnson operates in pharmaceuticals and medical devices, giving it exposure to two healthcare businesses. Its record of raising its dividend annually for more than 50 consecutive years places it among the companies known as Dividend Kings. The dividend yield cited in the review is 2%, approximately double the yield available from an S&P 500 index fund. The review identifies continued spending on health and quality of life as a feature of demand for healthcare products.
Medtronic concentrates on medical devices and is approaching Dividend King status. Its dividend yield is 3%, the highest of the four companies discussed. Revenue increased by nearly 14% during the opening quarter of its 2027 financial year. Following that quarter, management raised its revenue and earnings targets for the full year. The review also identifies the company's Hugo surgical robot among its new products and considers those products potential contributors to growth over both shorter and longer periods.
Coca-Cola and Procter & Gamble are also Dividend Kings, and both rank among the largest consumer-staples companies worldwide. The review describes the sector as supplying comparatively inexpensive items purchased repeatedly, including food and personal-care products. It identifies regular purchasing and consumer attachment to particular brands as characteristics of these businesses, while discussing their operations against a backdrop of higher costs and consumers reducing expenditure.
Coca-Cola sells beverages internationally through a portfolio of established brands. In the second quarter of 2026, its organic sales increased by 6%, while case volume advanced by 5%. The dividend yield cited for the company is 2.2%. The review characterises its drinks as affordable discretionary purchases with strong customer attachment and points to the quarterly sales and volume figures in its assessment of the business.
Procter & Gamble's product range includes toilet paper, toothpaste and medicines sold without prescriptions. Organic sales increased by 4% in the first quarter of its 2027 financial year. Its cited dividend yield is 2.7%, above Coca-Cola's. The company pursues a long-term product-innovation strategy intended to stimulate demand by offering improvements with practical benefits for customers.
For its historical comparison, the review uses a YCharts chart covering the Great Recession and the accompanying equity-market decline. Healthcare and consumer-staples shares suffered smaller declines than the wider market during that episode, according to the review's account of the chart. It also describes both sectors as recording stronger recoveries once the bear market ended. These sector-level comparisons form the historical basis for the review's selection of the four companies.

